Power Perspectives

Power Perspectives

Why Cancer Clinical Trials Move Slowly

Have you or a loved one had an experience asking about or participating in a clinical trial for cancer? Read Andrew's report on presenting survey data at a clinical trials conference with researchers who run clinical trials.

Andrew Schorr

Power Perspectives

FDA Approvals in Hematology and Oncology

The end of 2019 brought many new drug approvals in hematology and oncology from the U.S. Food & Drug Administration. Read Suzanne Mooney's Power Perspective for a breakdown of these drug approvals.

Suzanne Mooney

You all have been an invaluable, and most importantly, ACCURATE, resource. I tell so many folks about you!

— Monica, on Facebook

Latest News

Power Perspectives

Should We Be Concerned About the Coronavirus?

Andrew Schorr

Power Perspectives

2020: How Science, Policy Debates and Huge Companies Could Shake Your Cancer World

Andrew Schorr

Power Perspectives

Combining Cancer Medicines for Lower Cost

Andrew Schorr

Power Perspectives

Appreciating Cancer Detectives

Andrew Schorr

Power Perspectives

Facing Tough Stories Head-On

Andrew Schorr

Power Perspectives

The President vs. Prescription Drug Prices

Andrew Schorr

Power Perspectives

The Million Dollar Cancer Treatment? Don't Let Them Scare You

Andrew Schorr

Power Perspectives

Paying the Price for Misinformation

Andrew Schorr

Power Perspectives

Patients' Paradox, Doctors' Dilemma

Andrew Schorr

Power Perspectives

Top Hematologists Weigh in on Cancer Medicine Cost Controversy

Andrew Schorr

Power Perspectives

Medicare to Cover Genetic Sequencing in Cancer Patients

Andrew Schorr

Power Perspectives

The President’s Cancer Panel: Promoting Value, Affordability and Innovation

Andrew Schorr

Find a clinical trial

Learn More